GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTC Bio Inc (XKRX:060590) » Definitions » Enterprise Value

CTC Bio (XKRX:060590) Enterprise Value : ₩205,238 Mil (As of Jun. 23, 2024)


View and export this data going back to 2002. Start your Free Trial

What is CTC Bio Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CTC Bio's Enterprise Value is ₩205,238 Mil. CTC Bio's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-11,999 Mil. Therefore, CTC Bio's EV-to-EBIT ratio for today is -17.11.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, CTC Bio's Enterprise Value is ₩205,238 Mil. CTC Bio's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-6,485 Mil. Therefore, CTC Bio's EV-to-EBITDA ratio for today is -31.65.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, CTC Bio's Enterprise Value is ₩205,238 Mil. CTC Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩135,825 Mil. Therefore, CTC Bio's EV-to-Revenue ratio for today is 1.51.


CTC Bio Enterprise Value Historical Data

The historical data trend for CTC Bio's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTC Bio Enterprise Value Chart

CTC Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 163,520.30 196,258.28 239,697.56 166,232.87 266,433.92

CTC Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 241,116.68 247,462.69 285,333.78 266,433.92 221,974.69

Competitive Comparison of CTC Bio's Enterprise Value

For the Biotechnology subindustry, CTC Bio's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CTC Bio's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CTC Bio's Enterprise Value distribution charts can be found below:

* The bar in red indicates where CTC Bio's Enterprise Value falls into.



CTC Bio Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

CTC Bio's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

CTC Bio's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CTC Bio  (XKRX:060590) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

CTC Bio's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=205238.335/-11998.706
=-17.11

CTC Bio's current Enterprise Value is ₩205,238 Mil.
CTC Bio's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-11,999 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

CTC Bio's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=205238.335/-6484.969
=-31.65

CTC Bio's current Enterprise Value is ₩205,238 Mil.
CTC Bio's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-6,485 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

CTC Bio's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=205238.335/135824.751
=1.51

CTC Bio's current Enterprise Value is ₩205,238 Mil.
CTC Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩135,825 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CTC Bio Enterprise Value Related Terms

Thank you for viewing the detailed overview of CTC Bio's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


CTC Bio (XKRX:060590) Business Description

Traded in Other Exchanges
N/A
Address
94, Saengmyeonggwahakgwan-gil, Gangwon-do, Hongcheon, KOR, 25142
CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.

CTC Bio (XKRX:060590) Headlines

No Headlines